Lilly announces details of presentations at American Diabetes Association's (ADA) 85th Scientific Sessions. PR Newswire . Thu, May 29, 2025, 2:00 PM 22 min read. In This Article: LLY .

The American Diabetes Association and Abbott recently announced a collaboration to better understand the nutritional needs of people living with diabetes, obesity and metabolic dysfunction.

Research presented at the American Diabetes Association (ADA) annual meeting included a small phase I/II study on stem cell ...

Vertex Pharmaceuticals Incorporated ( NASDAQ: VRTX) American Diabetes Association (ADA) 85th Scientific Sessions Conference June 20, 2025 8:15 PM ET James Markmann - Corporate Participant Michael ...

The American Diabetes Association® (ADA) and Abbott recently announced a collaboration to better understand the nutritional needs of people living with diabetes, obesity, and metabolic ...

THE WOODLANDS, Texas, June 18, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LXRX) today announced that data from a study evaluating the impact of sotagliflozin on hypoglycemia in people ...

UAB Comprehensive Diabetes Center (UCDC) scientist Kirk Habegger, Ph.D., is featured in the Diabetes Spotlight in the May 2025 issue of Diabetes, the flagship research publication of the American ...

ARLINGTON, Va., May 6, 2025 /PRNewswire/ -- Today, the American Diabetes Association® (ADA) announced the appointment of Rita Rastogi Kalyani, MD, MHS, as its new chief scientific and medical ...

Presentation Highlights Orforglipron: In an ADA- sponsored symposium, Lilly will share results from the ACHIEVE-1 Phase 3 trial, which evaluated the safety and efficacy of orforglipron in adults ...

In an ADA-sponsored symposium, Lilly will share results from the ACHIEVE-1 Phase 3 trial, which evaluated the safety and efficacy of orforglipron in adults with type 2 diabetes and inadequate ...